DAX24.702 +2,3%Est506.058 +2,1%MSCI World4.343 -0,1%Top 10 Crypto9,5500 -4,7%Nas24.468 +1,5%Bitcoin64.768 -1,1%Euro1,1763 ±0,0%Öl90,38 -8,0%Gold4.834 +1,0%

Janux Therapeutics Aktie

Kaufen

Verkaufen

15,81 USD +0,63 USD +4,12 %

nachbörslich17.04.2026

BTT

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Smartphone

Marktkap.785,54 Mio. EUR

Div. Rendite0,00%

WKNA3CR8F

ISINUS47103J1051

SymbolJANX

Janux Therapeutics Aktien News

Sortieren:Datum Meistgelesen

02.04.26ZacksJanux Therapeutics Secures $35M Milestone Payment From BMY Deal

03.02.26ZacksWall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

22.01.26BenzingaJanux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

02.12.25BenzingaJanux Therapeutics Stock Hits 52-Week Low After Trial Update

02.12.25BenzingaSignet Jewelers, Janux Therapeutics, BW LPG And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

07.11.25ZacksJanux Therapeutics, Inc. (JANX) Reports Q3 Loss, Tops Revenue Estimates

29.10.25ZacksJanux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last?

10.10.25ZacksJanux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?

05.12.24BusinesswireJanux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

03.12.24BusinesswireJanux Therapeutics Announces Proposed Public Offering

25.11.24BusinesswireJanux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

06.11.24BusinesswireJanux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

07.08.24BusinesswireJanux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

22.07.24BusinesswireJanux Therapeutics Announces Updates to Board of Directors

07.05.24BusinesswireJanux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

08.03.24BusinesswireJanux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

29.02.24BusinesswireJanux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

27.02.24BusinesswireJanux Therapeutics Announces Proposed Public Offering of Common Stock

26.02.24BusinesswireJanux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

20.02.24BusinesswireJanux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008

08.01.24BusinesswireJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer

07.11.23BusinesswireJanux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

08.08.23BusinesswireJanux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

17.07.23BusinesswireJanux Therapeutics Announces Pricing of $60 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

17.07.23BusinesswireJanux Therapeutics Announces Positive Interim Clinical Data from Phase 1a Dose Escalation for PSMA-TRACTr JANX007 and an Update on Pipeline Programs

09.05.23BusinesswireJanux Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

24.04.23BusinesswireJanux Therapeutics to Participate at Upcoming May 2023 Investor Conferences

20.04.23BusinesswireJanux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

Janux Therapeutics News

Janux Therapeutics News: auf dieser Seite finden Sie alle Janux Therapeutics News und Nachrichten zur Janux Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Janux Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Janux Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.